About Jean-Francois Ducrest
Jean-Francois Ducrest is a director at Lytica Therapeutics.
Jean-Francois Ducrest first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jean-Francois Ducrest in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jean-Francois Ducrest works with at each company, as listed on that company's latest Form D.
Lytica Therapeutics, Inc. · Form D, Apr 11, 2025